Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 4 minute read Pharma Industry News Cloudbreak Pharma announces positive clinical results for vascularized pinguecula therapy CBT-004 shows significant efficacy and safety in Phase 2 trial for vascularized pinguecula; experts cite breakthrough in non-steroidal treatment. bySoujanya RaviJuly 21, 2025